Literature DB >> 32316383

Fold-Change-Specific Enrichment Analysis (FSEA): Quantification of Transcriptional Response Magnitude for Functional Gene Groups.

Daniil S Wiebe1, Nadezhda A Omelyanchuk1, Aleksei M Mukhin1, Ivo Grosse2,3, Sergey A Lashin1,4, Elena V Zemlyanskaya1,4, Victoria V Mironova1,4.   

Abstract

Gene expression profiling data contains more information than is routinely extracted with standard approaches. Here we present Fold-Change-Specific Enrichment Analysis (FSEA), a new method for functional annotation of differentially expressed genes from transcriptome data with respect to their fold changes. FSEA identifies Gene Ontology (GO) terms, which are shared by the group of genes with a similar magnitude of response, and assesses these changes. GO terms found by FSEA are fold-change-specifically (e.g., weakly, moderately, or strongly) affected by a stimulus under investigation. We demonstrate that many responses to abiotic factors, mutations, treatments, and diseases occur in a fold-change-specific manner. FSEA analyses suggest that there are two prevailing responses of functionally-related gene groups, either weak or strong. Notably, some of the fold-change-specific GO terms are invisible by classical algorithms for functional gene enrichment, Singular Enrichment Analysis (SEA), and Gene Set Enrichment Analysis (GSEA). These are GO terms not enriched compared to the genome background but strictly regulated by a factor within specific fold-change intervals. FSEA analysis of a cancer-related transcriptome suggested that the gene groups with a tightly coordinated response can be the valuable source to search for possible regulators, markers, and therapeutic targets in oncogenic processes. Availability and Implementation: FSEA is implemented as the FoldGO Bioconductor R package and a web-server.

Entities:  

Keywords:  enrichment analysis; gene expression; gene ontology; transcriptomics

Year:  2020        PMID: 32316383      PMCID: PMC7230499          DOI: 10.3390/genes11040434

Source DB:  PubMed          Journal:  Genes (Basel)        ISSN: 2073-4425            Impact factor:   4.096


  29 in total

Review 1.  Calreticulin in phagocytosis and cancer: opposite roles in immune response outcomes.

Authors:  Alejandro Schcolnik-Cabrera; Bernardo Oldak; Mandy Juárez; Mayra Cruz-Rivera; Ana Flisser; Fela Mendlovic
Journal:  Apoptosis       Date:  2019-04       Impact factor: 4.677

2.  On the importance of small changes in RNA expression.

Authors:  Georges St Laurent; Dmitry Shtokalo; Michael R Tackett; Zhaoqing Yang; Yuri Vyatkin; Patrice M Milos; Bernd Seilheimer; Timothy A McCaffrey; Philipp Kapranov
Journal:  Methods       Date:  2013-04-04       Impact factor: 3.608

3.  The Gene Expression Omnibus Database.

Authors:  Emily Clough; Tanya Barrett
Journal:  Methods Mol Biol       Date:  2016

4.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.

Authors:  T Sørlie; C M Perou; R Tibshirani; T Aas; S Geisler; H Johnsen; T Hastie; M B Eisen; M van de Rijn; S S Jeffrey; T Thorsen; H Quist; J C Matese; P O Brown; D Botstein; P E Lønning; A L Børresen-Dale
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

5.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

6.  Cancerous inhibitor of protein phosphatase 2A promotes premature chromosome segregation and aneuploidy in prostate cancer cells through association with shugoshin.

Authors:  Rajash Pallai; Aishwarya Bhaskar; Natalie Barnett-Bernodat; Christina Gallo-Ebert; Joseph T Nickels; Lyndi M Rice
Journal:  Tumour Biol       Date:  2015-03-04

7.  Integration of Metabolomics and Transcriptomics Reveals Major Metabolic Pathways and Potential Biomarker Involved in Prostate Cancer.

Authors:  Shancheng Ren; Yaping Shao; Xinjie Zhao; Christopher S Hong; Fubo Wang; Xin Lu; Jia Li; Guozhu Ye; Min Yan; Zhengping Zhuang; Chuanliang Xu; Guowang Xu; Yinghao Sun
Journal:  Mol Cell Proteomics       Date:  2015-11-06       Impact factor: 5.911

8.  The transcription factor ERG increases expression of neurotransmitter receptors on prostate cancer cells.

Authors:  Haydn T Kissick; Seung T On; Laura K Dunn; Martin G Sanda; John M Asara; Kathryn L Pellegrini; Jonathan K Noel; Mohamed S Arredouani
Journal:  BMC Cancer       Date:  2015-08-27       Impact factor: 4.430

9.  Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs oxphos and prostate cancer metastatic spread.

Authors:  Elisa Giannoni; Maria Letizia Taddei; Andrea Morandi; Giuseppina Comito; Maura Calvani; Francesca Bianchini; Barbara Richichi; Giovanni Raugei; Nicholas Wong; Damu Tang; Paola Chiarugi
Journal:  Oncotarget       Date:  2015-09-15

10.  InterPro in 2019: improving coverage, classification and access to protein sequence annotations.

Authors:  Alex L Mitchell; Teresa K Attwood; Patricia C Babbitt; Matthias Blum; Peer Bork; Alan Bridge; Shoshana D Brown; Hsin-Yu Chang; Sara El-Gebali; Matthew I Fraser; Julian Gough; David R Haft; Hongzhan Huang; Ivica Letunic; Rodrigo Lopez; Aurélien Luciani; Fabio Madeira; Aron Marchler-Bauer; Huaiyu Mi; Darren A Natale; Marco Necci; Gift Nuka; Christine Orengo; Arun P Pandurangan; Typhaine Paysan-Lafosse; Sebastien Pesseat; Simon C Potter; Matloob A Qureshi; Neil D Rawlings; Nicole Redaschi; Lorna J Richardson; Catherine Rivoire; Gustavo A Salazar; Amaia Sangrador-Vegas; Christian J A Sigrist; Ian Sillitoe; Granger G Sutton; Narmada Thanki; Paul D Thomas; Silvio C E Tosatto; Siew-Yit Yong; Robert D Finn
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971

View more
  1 in total

1.  Identification of MATN3 as a Novel Prognostic Biomarker for Gastric Cancer through Comprehensive TCGA and GEO Data Mining.

Authors:  Pan Wang; Wei-Sheng Xiao; Yue-Hua Li; Xiao-Ping Wu; Hong-Bo Zhu; Ye-Ru Tan
Journal:  Dis Markers       Date:  2021-12-02       Impact factor: 3.434

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.